Russia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
August 2017
96
About the Report
About the Report
Russia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary
GlobalData's new report, "Russia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Russia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the Russia Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Products
Products
Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd
Companies
Teleflex Inc
B. Braun Melsungen AG
GlaxoSmithKline Plc
Baxter International Inc
AstraZeneca Plc
Boehringer Ingelheim GmbH
Fresenius Kabi AG
Medtronic Plc
Pfizer Inc
Merck & Co Inc
Becton Dickinson and Co
Smiths Medical
Hospira Inc
Teva Pharmaceutical Industries Ltd
Terumo Corp
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, Russia 11
3.1 Drug Delivery Devices Market, Russia, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, Russia, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, Russia, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, Russia, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, Russia, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, Russia, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, Russia, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, Russia, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, Russia 28
4.1 Central Venous Catheters Market, Russia, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, Russia, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, Russia, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, Russia, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, Russia, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, Russia, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, Russia 41
5.1 Infusion Systems Market, Russia, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
5.3 Central Venous Catheters Market, Russia, Revenue ($m), 2009-2016 43
5.4 Central Venous Catheters Market, Russia, Revenue ($m), 2016-2023 45
5.5 Central Venous Catheters Market, Russia, Volume (Units), 2009-2016 47
5.6 Central Venous Catheters Market, Russia, Volume (Units), 2016-2023 49
5.7 Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), 2015-2016 51
5.8 Central Venous Catheters Market, Russia, Company Share by Revenue ($m), 2016 52
6 Metered Dose Inhaler Devices Market, Russia 54
6.1 Metered Dose Inhaler Devices Market, Russia, Revenue ($m), 2009-2016 54
6.2 Metered Dose Inhaler Devices Market, Russia, Revenue ($m), 2016-2023 55
6.3 Metered Dose Inhaler Devices Market, Russia, Volume (Units), 2009-2016 56
6.4 Metered Dose Inhaler Devices Market, Russia, Volume (Units), 2016-2023 57
6.5 Metered Dose Inhaler Devices Market, Russia, Distribution Share by Revenue ($m), 2015-2016 58
6.6 Metered Dose Inhaler Devices Market, Russia, Company Share by Revenue ($m), 2016 59
7 Needle Free Injections Market, Russia 61
7.1 Needle Free Injections Market, Russia, Revenue ($m), 2009-2016 61
7.2 Needle Free Injections Market, Russia, Revenue ($m), 2016-2023 62
7.3 Needle Free Injections Market, Russia, Volume (Units), 2009-2016 63
7.4 Needle Free Injections Market, Russia, Volume (Units), 2016-2023 64
7.5 Needle Free Injections Market, Russia, Distribution Share by Revenue ($m), 2015-2016 65
7.6 Needle Free Injections Market, Russia, Company Share by Revenue ($m), 2016 66
8 Overview of Key Companies in Russia, Drug Delivery Devices Market 68
8.1 Teleflex Inc 68
8.1.1 Company Overview 68
8.2 B. Braun Melsungen AG 68
8.2.1 Company Overview 68
8.3 GlaxoSmithKline Plc 68
8.3.1 Company Overview 68
8.4 Baxter International Inc 68
8.4.1 Company Overview 68
8.5 AstraZeneca Plc 69
8.5.1 Company Overview 69
8.6 Boehringer Ingelheim GmbH 69
8.6.1 Company Overview 69
8.7 Fresenius Kabi AG 69
8.7.1 Company Overview 69
8.8 Medtronic Plc 69
8.8.1 Company Overview 69
8.9 Pfizer Inc 70
8.9.1 Company Overview 70
8.10 Merck & Co Inc 70
8.10.1 Company Overview 70
8.11 Becton Dickinson and Co 70
8.11.1 Company Overview 70
8.12 Smiths Medical 71
8.12.1 Company Overview 71
8.13 Hospira Inc 71
8.13.1 Company Overview 71
8.14 Teva Pharmaceutical Industries Ltd 71
8.14.1 Company Overview 71
8.15 Terumo Corp 71
8.15.1 Company Overview 71
9 Drug Delivery Devices Market Pipeline Products 72
10 Financial Deals Landscape 77
10.1 Asset Transactions 77
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 77
10.2 Partnerships 79
10.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida 79
10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical 80
10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 81
10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 82
10.2.5 Propeller Health Enters into Agreement with Novartis Pharma 84
10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 85
10.2.7 Pfizer Terminates its Licensing Agreement with pSivida 86
10.2.8 Clinigen Group Enters into Distribution Agreement with BioQ Pharma 87
10.2.9 Bayer Enters into Licensing Agreement with DelSiTech 88
10.2.10 BioCorRx Enters into Licensing Agreement with Therakine 89
11 Recent Developments 90
11.1 Corporate Communications 90
11.1.1 Nov 09, 2016: Clearside Biomedical names Rick McElheny as Vice President, Business Development 90
11.2 Strategy And Business Planning 90
11.2.1 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 90
12 Appendix 92
12.1 Research Methodology 93
12.1.1 Coverage 93
12.1.2 Secondary Research 93
12.1.3 Primary Research 94
12.1.4 Company Share Analysis 94
12.1.5 Distribution Share Analysis 94
12.1.6 Benchmarking 95
12.2 GlobalData Consulting 95
12.3 Contact Us 96
12.4 Disclaimer 96
List of Figure
1.2 List of Figures
Figure 1: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, Russia, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, Russia, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 20
Figure 8: Drug Delivery Devices Market, Russia, Volume (Units), Historic, 2009-2016 22
Figure 9: Drug Delivery Devices Market, Russia, Volume (Units), Forecast, 2016-2023 24
Figure 10: Drug Delivery Devices Market, Russia, Company Share (%) 2016 26
Figure 11: Central Venous Catheters Market, Russia, Revenue Mix ($m), 2016 28
Figure 12: Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
Figure 13: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 14: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 15: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 34
Figure 16: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 36
Figure 17: Central Venous Catheters Market, Russia, Company Share (%) 2016 39
Figure 18: Infusion Systems Market, Russia, Revenue Mix ($m), 2016 41
Figure 19: Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
Figure 20: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 43
Figure 21: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Figure 22: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 47
Figure 23: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 49
Figure 24: Central Venous Catheters Market, Russia, Company Share (%) 2016 52
Figure 25: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 54
Figure 26: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 55
Figure 27: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Historic, 2009-2016 56
Figure 28: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Forecast, 2016-2023 57
Figure 29: Metered Dose Inhaler Devices Market, Russia, Company Share (%) 2016 59
Figure 30: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 61
Figure 31: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 62
Figure 32: Needle Free Injections Market, Russia, Volume (Units), Historic, 2009-2016 63
Figure 33: Needle Free Injections Market, Russia, Volume (Units), Forecast, 2016-2023 64
Figure 34: Needle Free Injections Market, Russia, Company Share (%) 2016 66
List of Table
1.1 List of Tables
Table 1: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, Russia, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, Russia, Category Comparison by Revenue ($m), 2009-2023 15
Table 4: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 5: Drug Delivery Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 6: Drug Delivery Devices Market, Russia, Volume (Units), 2009-2023 21
Table 7: Drug Delivery Devices Market, Russia, Volume (Units), Historic, 2009-2016 23
Table 8: Drug Delivery Devices Market, Russia, Volume (Units), Forecast, 2016-2023 25
Table 9: Drug Delivery Devices Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 27
Table 10: Central Venous Catheters Market, Russia, Segment Contribution (%), 2016 29
Table 11: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 12: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 13: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 35
Table 14: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 37
Table 15: Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 16: Central Venous Catheters Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 40
Table 17: Infusion Systems Market, Russia, Segment Contribution (%), 2016 42
Table 18: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 44
Table 19: Central Venous Catheters Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Table 20: Central Venous Catheters Market, Russia, Volume (Units), Historic, 2009-2016 48
Table 21: Central Venous Catheters Market, Russia, Volume (Units), Forecast, 2016-2023 50
Table 22: Central Venous Catheters Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 51
Table 23: Central Venous Catheters Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 53
Table 24: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 54
Table 25: Metered Dose Inhaler Devices Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 55
Table 26: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Historic, 2009-2016 56
Table 27: Metered Dose Inhaler Devices Market, Russia, Volume (Units), Forecast, 2016-2023 57
Table 28: Metered Dose Inhaler Devices Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 58
Table 29: Metered Dose Inhaler Devices Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 60
Table 30: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Historic, 2009-2016 61
Table 31: Needle Free Injections Market, Russia, Revenue ($m), USD Constant, Forecast, 2016-2023 62
Table 32: Needle Free Injections Market, Russia, Volume (Units), Historic, 2009-2016 63
Table 33: Needle Free Injections Market, Russia, Volume (Units), Forecast, 2016-2023 64
Table 34: Needle Free Injections Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 65
Table 35: Needle Free Injections Market, Russia, Company Share by Revenue ($m), USD Constant, 2016 67
Table 36: Drug Delivery Devices Market Pipeline Products 72
Table 37: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 77
Table 38: Alimera Sciences Enters into Licensing Agreement with pSivida 79
Table 39: Bluegrass Vascular Enters into Partnership with Merit Medical 80
Table 40: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 81
Table 41: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 82
Table 42: Propeller Health Enters into Agreement with Novartis Pharma 84
Table 43: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 85
Table 44: Pfizer Terminates its Licensing Agreement with pSivida 86
Table 45: Clinigen Group Enters into Distribution Agreement with BioQ Pharma 87
Table 46: Bayer Enters into Licensing Agreement with DelSiTech 88
Table 47: BioCorRx Enters into Licensing Agreement with Therakine 89
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.